Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
ID: 353623Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353623

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PA-24-201.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Emergency Competitive Revision to Existing NIH Awards," aimed at supporting applications related to disasters declared under the Stafford Act or public health emergencies. This initiative is designed for organizations holding active NIH awards that respond to specific Emergency Notices of Special Interest (NOSIs), with a focus on addressing urgent public health crises. Eligible applicants include a diverse range of entities such as universities, nonprofits, and government organizations, with particular encouragement for minority-serving institutions. There are no set limits on funding amounts, but budgets must accurately reflect project needs, and applications must be submitted by April 18, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-24-201.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PA-24-201.html
    The National Institutes of Health (NIH) announced a funding opportunity under the "Emergency Competitive Revision to Existing NIH Awards" initiative, aimed at supporting applications related to disasters declared under the Stafford Act or public health emergencies. This funding is intended for organizations holding active NIH awards and responding to specific Emergency Notices of Special Interest (NOSIs). Applicants must adhere to strict guidelines and submit through designated electronic platforms, while ensuring compliance with NIH policies. Although there are no set limits on funding amounts, requested budgets must accurately reflect actual project needs. Eligible applicants include a wide range of organizations such as universities, nonprofits, and government entities, with particular encouragement for minority-serving institutions. The announcement underlines the importance of timely project execution, considering emergency circumstances, thus prioritizing applications addressing urgent public health crises. The review process highlights an overall impact score based on the proposal's potential to contribute significantly to health research. Successful applicants will receive detailed funding conditions aligned with the NIH Grants Policy Statement and must provide regular reporting as mandated for NIH awards.
    Similar Opportunities
    Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for competing revisions to existing Single Project Research Grants and Cooperative Agreements, with the option for clinical trials. This initiative allows NIH award recipients to apply for additional funds to expand their current projects within the relevant Institutes and Centers, specifically in response to Notices of Special Interest (NOSI) issued by participating NIH entities. The funding opportunity, identified as PA-23-317, is open to a wide range of eligible applicants, including higher education institutions, nonprofit organizations, and foreign entities, reflecting NIH's commitment to advancing impactful health research. Applications must be submitted by November 24, 2026, through the NIH ASSIST system or Grants.gov, and will be evaluated based on scientific merit and adherence to specified criteria. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities (R01- Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities" (FON: PAR-24-109), aimed at supporting collaborative research into the impacts of disasters on healthcare systems serving vulnerable populations in the U.S. and its territories. The initiative focuses on understanding the long-term effects, defined as one year or more post-disaster, on access, delivery, and quality of healthcare services, with an emphasis on fostering resilience and mitigating disparities exacerbated by such events. Eligible applicants include a wide range of institutions, including educational organizations, nonprofits, and government entities, with a funding ceiling of $500,000. The application period opens on May 5, 2024, and closes on June 5, 2024, with further inquiries directed to NIH Grants Information at grantsinfo@nih.gov.
    Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for administrative supplements to existing NIH grants and cooperative agreements, allowing current recipients to request additional funding for unforeseen increased costs within the scope of their approved projects. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, for-profits, and government entities, provided they hold an active parent award. This opportunity is crucial for supporting ongoing health-related research by addressing unexpected financial needs that arise during the project lifecycle. Interested parties must ensure compliance with submission guidelines and can contact the Division of Grants Policy at GrantsPolicy@od.nih.gov for further information; the application deadline is November 30, 2028.
    Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for organizations seeking to change the recipient organization of specific NIH grants. This initiative allows eligible applicants, including higher education institutions, nonprofits, and various government entities, to submit applications for the transfer of grant awards, ensuring continuity in research projects. While the submission of applications does not guarantee approval for the transfer, the NIH encourages coordination with relevant institutes and adherence to grant policies to facilitate a smooth transition. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with key submission dates starting from July 12, 2024, and the opportunity closing on July 12, 2027.
    Research Opportunities in Crisis Response Services for Suicide Prevention
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity for research focused on crisis response services aimed at suicide prevention. This initiative seeks to examine the effectiveness and implementation of crisis response practices, with an emphasis on improving the quality and outcomes of interventions in real-world settings, while considering various psychosocial factors and health disparities. The total estimated funding for this program is $2 million, with approximately five awards expected to be granted. Interested applicants, particularly small businesses with expertise in crisis response and suicide prevention, are encouraged to prepare for this opportunity, with the anticipated synopsis posting date on September 8, 2025, and a closing date for applications on October 8, 2025. For further inquiries, potential applicants can contact Dr. Jennifer Humensky at jennifer.humensky@nih.gov or by phone at 301-480-1265.
    Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Research With Activities Related to Diversity (ReWARD)" (PAR-23-122), aimed at enhancing diversity, equity, inclusion, and accessibility (DEIA) within the biomedical research workforce. This grant supports scientists who significantly contribute to DEIA and currently lack NIH research project funding, providing resources for both scientific research and ongoing DEIA activities aligned with the interests of participating NIH Institutes and Centers. The initiative is crucial for addressing underrepresentation in biomedical research and fostering innovative collaborations that promote inclusivity. Interested applicants, including higher education institutions and tribal governments, must submit a Diversity Statement and a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application, with the submission deadline set for May 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for competitive revisions to support clinical trials in somatic cell genome editing, specifically under the funding opportunity RFA-RM-24-008. This initiative aims to expand the existing Somatic Cell Genome Editing program by soliciting applications from awardees with active U19 awards funded under RFA-RM-22-015, which previously did not allow clinical trials. The funding will facilitate first-in-human genome editing clinical trials, including essential preparatory activities such as patient recruitment, regulatory approvals, and the development of clinical trial designs. Interested applicants must submit their proposals by February 13, 2026, and can find additional information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Forecast for The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the NINDS Human Biospecimen and Data Repository, aimed at advancing research in neurological disorders. This initiative will establish a repository to maintain and expand a collection of biospecimens, which will be made available to qualified academic and industry researchers to support basic, translational, and clinical research efforts. The total estimated funding for this program is $1,950,000, with one award anticipated, and interested applicants are encouraged to begin forming collaborations and developing proposals ahead of the expected synopsis posting on August 25, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Price at rebecca.price@nih.gov or by phone at 301-827-3587.
    Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants," aimed at accelerating the clinical validation of biomarker assays for cancer detection, diagnosis, prognosis, and treatment response. This initiative encourages multidisciplinary collaboration among researchers, clinicians, and statisticians, focusing on assays that have nearly completed analytical validation and utilize human specimens. The funding amount is capped at $150,000 per year for a maximum duration of three years, with application deadlines starting from January 14, 2025, and concluding on October 15, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Interdisciplinary Research Networks to Advance Biomedical Research on Resilience and Health Optimization
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interdisciplinary Research Networks to Advance Biomedical Research on Resilience and Health Optimization." This initiative aims to support the establishment of interdisciplinary research networks that focus on resilience, defined as the ability to resist, recover, adapt, or grow from various stressors affecting health and well-being. The program is particularly significant as it addresses the increasing challenges faced by Americans, such as chronic diseases exacerbated by stressors like viral infections and environmental factors. The estimated total funding for this program is $1.5 million, with three awards expected to be granted. Interested applicants can reach out to Erin Burke Quinlan, Ph.D., at erin.quinlan@nih.gov or by phone at 301-480-9483 for further information. The application process is set to open with a synopsis posted on January 5, 2026, and will close on May 25, 2026, with awards anticipated by April 1, 2027.